Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-amoxiclav in children with drug-resistant epilepsy
IRCT20090412001808N8Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of amoxicillin + clavulanate in epilepsy (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Seizure frequency before and after co-amoxiclav and Intestinal microbiota changes before and after co-amoxiclav. Started Jun 2022; status: completed.
02
Drugs
amoxicillin + clavulanate
03
Conditions
epilepsy
Beyond the preview
Go deeper on IRCT20090412001808N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090412001808N8.